Zydus Worldwide DMCC Commences Tender Offer for Assertio Holdings at $23.50/Share
ASRT has more than doubled off its 52-week low of $8.61.
Summary
Assertio Holdings announced that Zydus Worldwide DMCC has commenced its cash tender offer to acquire all outstanding shares for $23.50 per share, progressing the previously announced merger.
Key Events · M&A and Partnerships · ASRT
-
Tender Offer Commenced
Purchaser, a subsidiary of Zydus Worldwide DMCC, has commenced a cash tender offer to acquire all outstanding shares of Assertio Holdings, Inc. for $23.50 per share.
-
Convertible Note Offer Waived
Parent (Zydus Worldwide DMCC) waived the requirement for Assertio to make an offer and consent solicitation to repurchase its 6.50% Convertible Senior Notes due 2027.
-
Convertible Noteholder Rights
The merger constitutes a 'Fundamental Change' and 'Make-Whole Fundamental Change' under the Convertible Notes indenture, granting holders rights to repurchase or convert their notes.
Analysis · ASRT · Life Sciences
This 8-K formalizes the tender offer process for the previously announced acquisition of Assertio Holdings by Zydus Worldwide DMCC. The commencement of the tender offer is a critical procedural step towards closing the merger, providing a clear path for shareholders to tender their shares. Additionally, the waiver of the Note Offer for convertible senior notes simplifies the transaction for the acquirer.
At the time of this filing, ASRT was trading at $23.32 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $150.7M. The 52-week trading range was $8.61 to $23.36. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.